The FDA has granted marketing authorization for the use of the Ellipsys Vascular Access System and the everlinQ endoAVF System to make percutaneous arteriovenous fistulas for patients with CKD who are on hemodialysis.
The Ellipsys Vascular Access System, which will be marketed by Avenu Medical, uses one catheter. The everlinQ endoAVF System, which will be marketed by TVA Medical Inc.,
This activity is supported by an educational grant from ViiV Healthcare.
No commercial support for this activity.
Transplant Centers Resource Center
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.